MedActive: A Smartphone Intervention to Improve Adherence to Antipsychotic Medications

Completed · Not applicable

Conditions studied: Schizophrenia

In brief

We propose to develop and pilot test the effect of a mobile smartphone intervention, MedActive, on improving antipsychotic adherence among individuals with schizophrenia.

Key facts

Study ID

NCT01953237

Run by

University of Maryland, Baltimore

People needed

31

Starts

2013-09-01

Expected to finish

2015-12-01

Last updated by the study team

2019-08-28

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Decisional capacity to provide informed consent
• Chart diagnosis of schizophrenia or schizoaffective disorder
• Currently prescribed at least one oral antipsychotic medication
• Self administers at least one oral antipsychotic medication
• 18-64 years of age
• English Speaking
• Be able to read English

You may not qualify if…

• Has visual, hearing, voice, or motor impairment that would prevent completion of study procedures or use of mobile phone

Where it is running

• Outpatient clinics within the University of Maryland Division of Community Psychiatry — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.